Position in NVO
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$479,400
+$88,527 QoQ
Shares Held
10,000
-6.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#724
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIVERSIFIED MANAGEMENT INC holds $8,173,871 across 7 Drug Manufacturers - General names. NVO ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,013 | $2,414,452 | |
| 2 | JNJ |
Johnson & Johnson
|
7,731 | $1,963,442 | |
| 3 | ABBV |
AbbVie Inc.
|
5,888 | $1,481,656 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,961 | $1,151,488 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
10,000 | $479,400 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,870 | $362,595 | |
| 7 | AMGN |
Amgen Inc
|
886 | $320,838 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,400 | 10,000 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $390,873 | 10,636 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $508,800 | 10,000 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||